Ventyx Biosciences Inc (NASDAQ: VTYX) on Friday, soared 10.78% from the previous trading day, before settling in for the closing price of $2.69. Within the past 52 weeks, VTYX’s price has moved between $0.78 and $3.39.
Annual sales at Healthcare sector company slipped by -87.13% over the past five years. The company achieved an average annual earnings per share of 14.94%. With a float of $63.19 million, this company’s outstanding shares have now reached $71.23 million.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 11.39%, while institutional ownership is 62.25%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.5 earnings per share (EPS) for the period topping the consensus outlook (set at -0.51) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.85% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 19.12 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.68, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 1.28 million, a negative change from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 76.85%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 83.92%, which indicates a significant decrease from 98.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.66, while its 200-day Moving Average is $2.02. Nevertheless, the first resistance level for the watch stands at $3.09 in the near term. At $3.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.42. If the price goes on to break the first support level at $2.77, it is likely to go to the next support level at $2.55. The third support level lies at $2.44 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 212.50 million based on 71,309K outstanding shares. Right now, sales total 0 K and income totals -135,120 K. The company made 0 K in profit during its latest quarter, and -26,990 K in sales during its previous quarter.
